n-(2-Bromophenyl)tetrahydro-2h-pyran-4-amine, 95%, 5g

3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 97%, 250mg

HPLC column NUCLEODUR® C18 Gravity 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

(2-Methyl-5-(piperidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 1g

2-(2-Methoxyethoxy)ethanamine, 95.0%, 100mg

Methyl 3,4-dimethoxybenzoate, 95.0%, 100g

7-BROMO-2-METHYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE, 97.0%, 250mg

tert-Butyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8-carboxylate, 97%, 500mg

3,5-Dichloro-2-hydrazinylpyridine, 95.0%, 100mg

(3-Chloro-2-hydroxyphenyl)boronic acid, 95.0%, 250mg

1-tert-Butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate, 95%, 10g

1-(3-Chlorophenyl)-3-(3-pyridinyl)-1H-pyrazole-4-carbaldehyde, 250mg

N-Methyl-O-methyl-L-tyrosine hydrochloride, 98.0%, 250mg